The liver is one of the hardest working organs in the human body. It detoxifies harmful substances, helps with digestion, ...

Sarepta Therapeutics Inc. plummeted after reporting a second patient died of acute liver failure while being treated with its gene therapy for a rare muscle disorder.

Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other ...

The only option left for the doctors was liver transplantation and Anakendu's mother came to her rescue by volunteering to ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety ...

Just weeks after beginning the supplement in late February, she began experiencing symptoms she couldn’t ignore — yellowing ...

The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.

Sarepta Therapeutics shares dived 42% in premarket trading after the company disclosed a second reported case of acute liver failure that resulted in a death tied to its Duchenne muscular dystrophy ...

Another person treated with Elevidys suffered acute liver failure, leading Sarepta to discontinue treatment in certain ...

She noted that constantly feeling fatigued or tired could be due to other lifestyle factors such as simply not getting enough ...

A second patient with Duchenne muscular dystrophy has died from acute liver failure after receiving the gene therapy Elevidys ...